TAKE THIS POLL |
|
|
- Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitr 17 May 2008 13:18 GMT
... plasma collection networks, ZLB Plasma. CSL Behring is a subsidiary of CSL Limited, a biopharmaceutical company with headquarters inMelbourne, Australia. For more information, visit Media Contact: Sheila A. Burke ...
- Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awarene 17 May 2008 12:31 GMT
... plasma collection networks, ZLB Plasma. CSL Behring is a subsidiary of CSL Limited, a biopharmaceutical company with headquarters in Melbourne, Australia. For more information, visit Media Contact: Sheila A. ...
- Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 17 May 2008 12:31 GMT
... plasma collection networks, ZLB Plasma. CSL Behring is a subsidiary of CSL Limited, a biopharmaceutical company with headquarters in Melbourne, Australia. For more information, visit Media Contact: Sheila A. ...
- Nexavar Significantly Improves Overall Survival By 47 Percent In Asia Pacific Liver Cancer Study 17 May 2008 09:09 GMT
... diagnosing, preventing and treating diseases. About Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration ...
- Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions In Blood Pressure In Hypertensive Patient 17 May 2008 07:38 GMT
... when they bind to these receptors. About Pharmacopeia Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical ...
- Clinical Data for MethylGene's MGCD0103 to be Presented at the 2008 American Society of Clinical Oncology Annual Meeting 17 May 2008 06:20 GMT
... a.m. to 12:00 p.m. CDT MethylGene Inc. (TSX: MYG) is a publicly-traded, clinical stage, biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for cancer. The ...
- ERBITUX(R) (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Type K-Ras Metastatic Colorectal Cancer Patients in First-Line Setting 17 May 2008 06:19 GMT
... and stomatitis (25%, 10%). About ImClone Systems ImClone Systems Incorporated is a fully integrated biopharmaceutical company committed to advancing oncology care by developing and commercializing a portfolio of targeted ...
- Helix BioMedix Reports First Quarter 2008 Financial Results 17 May 2008 05:46 GMT
... the end of the year." About Helix BioMedix, Inc. Helix BioMedix, Inc. is a biopharmaceutical company with an extensive library of diverse bioactive peptides and patents covering six distinct ...
- Rexahn Pharmaceuticals Receives AMEX Listing Approval 17 May 2008 05:46 GMT
... Rexahn Pharmaceuticals, Inc. (OTC BB:RXHN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, central ...
- TetraQ recognized for toxicology services 17 May 2008 05:40 GMT
... had now positioned TetraQ as the leading integrated preclinical service provider to the Australian biopharmaceutical industry. TetraQ's decision to offer toxicology services, including toxicokinetics, allows us to leverage our ...
- Cytokinetics Announces Addition to Board of Directors 17 May 2008 05:37 GMT
... to Cytokinetics as we build our company towards its goal of becoming a sustainable biopharmaceutical business." Cytokinetics is a biopharmaceutical company focused on the discovery, development and commercialization of ...
- Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 17 May 2008 05:18 GMT
... Initiate a Phase 1 trial for MEM 68626 by year-end. Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, ...
- Inspire Receives Milestone Payment for Completion of Phase 3 Testing in Japan for Dry Eye Program 17 May 2008 05:17 GMT
... royalty stream for Inspire, if the product is approved." About Inspire Inspire is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products for diseases in the ...
- Accentia Biopharmaceuticals Reports Fiscal Second Quarter Financial Results 17 May 2008 05:17 GMT
... Accentia Biopharmaceuticals Reports Fiscal Second Quarter Financial Results ) announced today that the Company has filed ...
- Array BioPharma to Present at the Citi 2008 Global Healthcare Conference 17 May 2008 05:16 GMT
... New York, New York Webcast: www.arraybiopharma.com About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to ...
- Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 17 May 2008 05:16 GMT
... Roche's PEGASYS(R) for hepatitis C and Amgen's Neulasta(R) for neutropenia. Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug ...
- Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 17 May 2008 05:16 GMT
... and endothelin when they bind to these receptors. Pharmacopeia is a clinical development stage biopharmaceutical company dedicated to discovering and developing novel small molecule therapeutics to address significant medical ...
- Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 17 May 2008 04:41 GMT
... celiac patients are available online at: Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies to treat autoimmune and ...
- New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 17 May 2008 04:41 GMT
... Information Department at 1-866-VELCADE (1-866-835-2233). Millennium Pharmaceuticals, The Takeda Oncology Company, and a leading biopharmaceutical company based in , markets VELCADE, a novel cancer product, and has a robust ...
- Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 17 May 2008 04:41 GMT
... PEGINTRON at Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives ...
- Arpida Announces FDA Acceptance of the Iclaprim New Drug Application 17 May 2008 04:41 GMT
... which was compatible with treatment of patients with cSSSI. Arpida (SWX: ARPN) is a biopharmaceutical company with research facilities in Reinach, and in the . It focuses on the ...
- Icahn holds stake in Amylin, drops Macy's and CSX 17 May 2008 04:39 GMT
... Exchange Commission filing, Icahn reported holding 6.3 million shares of Amylin, a San Diego-based biopharmaceutical company. The investor had reported stakes in Macy's and CSX and in his fourth-quarter ...
- Omrix Biopharmaceuticals 17 May 2008 04:38 GMT
... and is noted for its in-depth research. Martin recently turned his analysis to Omrix Biopharmaceuticals (Nasdaq: ), a small-cap firm that operates in the biosurgical products and passive immunotherapy ...
- Gilead Sciences CEO exercises options 17 May 2008 04:37 GMT
... NEW YORK (AP) - The chairman and chief executive of biopharmaceutical company Gilead Sciences Inc. exercised options for 70,000 shares of common stock, according to ...
- CAPHOSOL relieves oral mucositis and improves quality-of-life in cancer patients 17 May 2008 04:35 GMT
... several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals ...
1 - 25 of 1901 next >
News by PR Newswire
|
